Sangamo Therapeutics, Inc. (SGMO) Tshuag Nqe hauv Lub Sijhawm
Tam sim no, koj tuaj yeem yuav Sangamo Therapeutics, Inc. Tshuag ntawm $ 0,45 ib feem. Txij li thaum pib ntawm hnub, SGMO tus nqi tau hloov los ntawm -1.98214%.
Sangamo Therapeutics, Inc. tus nqi qhib yog $0,463. Thaum lub sijhawm sib tham, tus nqi siab tshaj plaws tau mus txog yog $ 0,468 thaum qhov qis tshaj yog $ 0,45 thiab hnub kaw tus nqi yog $ 0,459.
Yuav tsum koj yuav Sangamo Biosciences shares - Cov duab tseem ceeb
[stock_market_widget type="leaderboard" template = "basic" cov cuab tam = "SGMO" realtime = "false" api = "yahoo-finance"]Tshaj li ib xyoos (dhau 52 lub lis piam), Sangamo Therapeutics, Inc. tus nqi Tshuag tau nce siab ntawm $ 2,84, thiab qhov qis tshaj nws mus txog 52 lub lis piam dhau los yog $ 0,38.
[stock_market_widget type=”gauge” template=”basic” cov cuab tam =”SGMO” low_high=”52_week_low_high” red_color=”#DB2828″ yellow_color=”#FBBD08″ green_color=”#21BA45″ animation_duration=”0″ api=”yahoo-finance”]Lub sijhawm 5 hnub ua lag luam kawg ntawm Sangamo Therapeutics, Inc. (SGMO) tus nqi tau hloov zuj zus raws li hauv qab no:
[stock_market_widget type = "rooj-history" template = "zebra4" cov cuab tam = "SGMO" teb = "hnub, qhib, siab, qis, kaw, ntim" ntau yam = "5d" ntu ntu = "1d" pagination = "false" rows_per_page= "5" sort_direction = "asc" alignment = "asc" ftp = "asc"Koj puas yuav tsum tau yuav Sangamo Therapeutics, Inc. koom rau lub Kaum Ob Hlis?
Tam sim no tus nqi Tshuag ntawm Sangamo Therapeutics, Inc. yog $ 0,45 thiab them ib feem ntawm ib feem! Lub Sangamo Therapeutics, Inc. cov nyiaj faib tawm tus nqi yog % ib xyoos yog tias koj yuav Sangamo Therapeutics, Inc. Tshuag ntawm tus nqi tam sim no.
[stock_market_widget type = "key-value-table-companies" template = "basic" cov cuab tam = "SGMO" fields = "logo_name, cim, kev lag luam, sector, website, xov tooj, neeg ua hauj lwm_count, lub teb chaws, full_address" api = "yahoo-nyiaj txiag"]Kuj tseem xav txog kev xaiv tus broker uas muaj qhov zoo ntawm kev muab kev ua tiav rau yuav cov stocks los ntawm thoob plaws lub ntiaj teb no! Qhov no yuav tso cai rau koj kom diversify koj cov ntaub ntawv tom qab.
Analyst Consensus and Price Target on Sangamo Therapeutics, Inc. Tshuag
[stock_market_widget type= » list » template = » Basic » color = » # 000000″ cov cuab tam = » SGMO » fields = » logo_name_symbol, pom zoo_key, phiaj_high_price,target_median_price,target_low_price,analyst_opinions » realtime = »Dividend Share Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. tsis tam sim no faib cov nyiaj faib tawm. Yog li ntawd, nws tsis tuaj yeem tsim cov nyiaj tau los passive tam sim no. Qhov no txhais tau hais tias cov khoom lag luam no tsuas yog muab cov peev txheej tau txais txiaj ntsig yog tias tus nqi nce rau yav tom ntej thiab raug muag ntawm tus nqi siab dua tus nqi yuav khoom.
[stock_market_widget type= » list » template = » Basic » color = » # 000000″ cov cuab tam = » SGMO » fields = » logo_name_symbol, txiaj, ex_dividend_date, dividend_rate, dividend_yield, 5_year_avg_dividend_yield,annual_dividual_rate, » api = "yahoo-finance"]Cov tswv cuab ntawm Sangamo Therapeutics, Inc.
Nov yog cov tswv cuab tam sim no ntawm Sangamo Therapeutics, Inc.:
- Wasatch Advisors LP – 9,702%
- Armistice peev LLC - 8,172%
- BIOGEN INC UA - 7,061%
- BlackRock Advisors LLC - IB 6,189%
- Vanguard Fiduciary Trust Co. 5,879%
- Acadian Asset Management LLC – 2,382%
- Geode Capital Management LLC – 1,621%
- DE Shaw & Co., Inc. – 1,478%
- STATE STREET CORPORATION – 1,326%
- - Renaissance Technologies LLC 1,252%
Cov neeg sib tw ntawm Sangamo Therapeutics, Inc.
Txawm hais tias cov neeg sib tw ncaj qha tuaj yeem sib txawv raws li kev tshwj xeeb thiab thaj chaw, ntawm no yog qee lub tuam txhab uas tuaj yeem suav tias muaj peev xwm sib tw rau Sangamo Therapeutics, Inc.:
- CRISPR Kev Kho Mob : Lub tuam txhab ua lag luam hauv kev txhim kho kev kho mob raws li CRISPR-Cas9 genome kho tshuab los kho ntau yam kab mob caj ces.
- Editas Tshuaj Kho Mob : Tshwj xeeb hauv kev kho genome los tsim kho cov noob rau cov kab mob loj, suav nrog cov kab mob ntawm lub qhov muag thiab cov kab mob neurological.
- Intellia Kev Kho Mob : tsom mus rau kev txhim kho cov noob caj noob ces siv CRISPR-Cas9 thev naus laus zis los kho ntau yam kab mob tsis tshua muaj caj ces.
- Vertex Cov Kev Tshuaj : Txawm hais tias thawj zaug tsom rau cov kab mob ua pa, Vertex tau nthuav dav rau hauv kev kho noob rau cov kab mob tsis tshua muaj caj ces xws li cystic fibrosis. (Yuav Vertex Pharmaceuticals Tshuag)
- Bluebird Bio Cov : tsom rau cov noob caj noob ces thiab kev kho mob ntawm tes rau cov kab mob tsis tshua muaj caj ces thiab cov ntshav tsis zoo, nrog rau cov khoom hauv kev txhim kho rau cov xwm txheej xws li kev tiv thaiv kab mob hnyav (SCID) thiab beta thalassemia.
- BioMarin Tshuaj : Tsim kho cov kab mob tsis tshua muaj caj ces, suav nrog cov kab mob metabolic, kab mob Pompe thiab phenylketonuria. (Yuav BioMarin Pharmaceutical Tshuag)
Cov tuam txhab no yog cov neeg sib tw ncaj qha lossis tsis ncaj ntawm Sangamo Therapeutics hauv kev kho cov noob caj noob ces thiab kev hloov kho caj ces. Kev sib tw hauv cov haujlwm no yog khaus vim qhov tseem ceeb ntawm kev nce qib hauv genomics thiab cov lus cog tseg ntawm cov noob kev kho mob los kho cov kab mob ib zaug suav tias yog kho tsis tau.
Cov neeg siv khoom ntawm Sangamo Therapeutics, Inc.
Sangamo Therapeutics (yav tas los Sangamo Biosciences) yog lub tuam txhab biopharmaceutical feem ntau tsom rau kev txhim kho cov noob thiab kev kho ntawm tes los kho ntau yam kab mob tsis tshua muaj thiab mob ntev. Raws li lub tuam txhab biotechnology, Sangamo tsis muaj ib txwm "cov neeg siv khoom" zoo li hauv lwm qhov kev lag luam. Hloov chaw, nws cuam tshuam nrog ntau tus neeg koom nrog tseem ceeb:
- Cov neeg mob : Cov neeg mob uas tsis tshua muaj kab mob caj ces yog Sangamo lub hom phiaj tseem ceeb ntawm cov pej xeem. Cov neeg mob no tuaj yeem tau txais txiaj ntsig los ntawm cov noob thiab cov kev kho mob ntawm tes tsim los ntawm lub tuam txhab los kho lawv cov mob.
- Cov kws kho mob : Sangamo ua haujlwm nrog cov kws kho mob, cov kws tshawb fawb thiab cov kws tshaj lij hauv kev tshuaj ntsuam genetic tshuaj los tsim thiab tswj nws cov kev tshawb nrhiav kev kho mob. Kev koom tes nrog cov kws kho mob tshwj xeeb yog qhov tseem ceeb los ua cov kev sim tshuaj thiab tau txais cov ntaub ntawv hais txog kev ua tau zoo thiab kev nyab xeeb ntawm kev kho mob.
- Biopharmaceutical kev lag luam koom tes : Sangamo feem ntau koom tes nrog lwm yam biotechnology, kws tshuaj thiab kev tshawb fawb tuam txhab hauv kev koom tes nrog kev sib koom tes. Cov kev sib koom tes no yuav suav nrog kev sib koom ua ke ntawm cov khoom siv tshiab, kev sib koom ua lag luam ntawm kev kho mob lossis kev nkag mus rau cov thev naus laus zis ntxiv.
- Investors thiab shareholders : Cov neeg ua lag luam thiab cov tswv lag luam ua lub luag haujlwm tseem ceeb hauv kev muab nyiaj rau kev tshawb fawb thiab kev tsim kho, nrog rau kev saib xyuas kev ua tau zoo nyiaj txiag thiab kev hloov pauv ntawm lub tuam txhab.
Cov piv txwv no tsis yog tag nrho, thiab Sangamo Therapeutics, Inc. cov npe ntawm cov neeg siv khoom yuav txawv nyob ntawm nws cov tswv yim kev lag luam thiab cov phiaj xwm loj hlob.
Vim li cas Invest in Sangamo Therapeutics, Inc. Tshuag
Kev nqis peev hauv Sangamo Therapeutics (yav tas los Sangamo Biosciences) cov khoom lag luam tuaj yeem txhawb nqa los ntawm ntau yam, nyob ntawm tus neeg ua lag luam cov kev nyiam tshwj xeeb thiab cov hom phiaj. Nov yog qee qhov laj thawj uas yuav xav txog kev nqis peev hauv lub tuam txhab no:
- Cov cuab yeej siv thev naus laus zis hauv kev kho noob : Sangamo Therapeutics yog ib lub tuam txhab biopharmaceutical tsom rau kev tsim kho noob thiab kev kho ntawm tes los kho ntau yam kab mob uas tsis tshua muaj thiab mob ntev. Kev nqis peev hauv Sangamo tuaj yeem ua rau muaj kev cuam tshuam rau kev lag luam ntawm lub hauv ntej ntawm kev kho mob tshiab.
- Promising khoom portfolio : Sangamo muaj ntau yam khoom sib tw hauv kev kho mob siab heev, tsom rau cov kab mob caj ces xws li hemophilia, Huntington's disease, fragile X syndrome thiab lwm yam kab mob tsis tshua muaj caj ces. Qhov muaj peev xwm ua tiav ntawm cov kev kho mob no tuaj yeem yog tus tsav tsheb loj hlob rau lub tuam txhab yav tom ntej.
- Kev sib koom tes zoo : Sangamo tau tsim kev koom tes nrog lwm cov tuam txhab tshuaj thiab biotechnology loj rau kev txhim kho thiab kev lag luam ntawm nws cov khoom, uas tuaj yeem nqa cov peev txheej ntxiv thiab kev loj hlob.
- Diversified pipeline : Ntxiv rau nws cov kev siv zog hauv kev kho noob, Sangamo kuj ua haujlwm hauv kev tiv thaiv kab mob thiab oncology. Ib lub raj xa dej sib txawv tuaj yeem txo qhov kev pheej hmoo cuam tshuam nrog kev nqis peev hauv lub tuam txhab biopharmaceutical.
- Kev tshawb fawb thiab kev kho mob nce qib : Kev nce qib ntxiv hauv kev tshawb fawb txog noob caj noob ces thiab kev sim tshuaj ntsuam xyuas tau zoo tuaj yeem ua rau cov neeg ua lag luam muaj kev ntseeg siab hauv Sangamo lub peev xwm kom ua tiav kev lag luam nws cov khoom.
Kev nqis peev hauv ib qho khoom lag luam tshwj xeeb xws li Sangamo Therapeutics, Inc. yuav tsum muaj kev tshawb fawb ntau thiab kev nkag siab txog kev pheej hmoo thiab cov hauv kev cuam tshuam nrog lub tuam txhab tshwj xeeb.
Koj tuaj yeem nqis peev hauv Sangamo Biosciences shares ntawm Nasdaq Tshuag Lag Luam (Nasdaq Tshuag Txauv).
